Survival Impact of Internal Mammary or Supraclavicular Lymphadenectomy
To evaluate the survival impact of extensive lymphadenectomy as part of debulking surgery in stage IVB ovarian cancer with supradiaphragmatic lymph node metastasis.
Ovarian Cancer Stage IV|Lymph Node Metastases
PROCEDURE: debulking surgery
Progression-free survival, the time interval from the treatment start date to disease recurrence or progression date, From date of treatment until the date of first documented progression or date of death (by any cause, in the absence of disease progression) whichever came first, assessed up to 120 months
Overall survival, the time interval from the treatment start date to death or end of study date, From the date of treatment start date until death due to any cause, assessed up to 120 months
To evaluate the survival impact of extensive lymphadenectomy as part of debulking surgery in stage IVB ovarian cancer with supradiaphragmatic lymph node metastasis.